Skip to main content
PMC home page
Cytotechnology logoLink to Cytotechnology
. 2002 May;39(1):9–14. doi: 10.1023/A:1022437514334

Use of Taguchi's methods as a basis to optimize hybridoma cell line growth and antibody production in a spinner flask

Héla Kallel 1, Hind Zaïri 2, Samia Rourou 1, Makram Essafi 2, Ridha Barbouche 2, Koussay Dellagi 2, Dahmani M Fathallah 2
PMCID: PMC3449801  PMID: 19003299

Abstract

Taguchi’s methods were used for the design of an experimental strategy aimed at optimizing cell density and monoclonal antibody (mAb) production from a spinner flask hybridoma culture. 23G11 is an antibody to the human leukocyte adhesion molecule, CR3 or β 2 integrin (CD11b/CD18). It recognizes specifically the A-domain of the α subunit CD11b. Anti β 2 integrin monoclonal antibodies hold a great potential for preventing inflammation mediated tissue injuries. An L8 orthogonal experimental design was used to investigate four different culture components: stirring speed, nature of serum, concentration of serum and nature of media (RPMI 1640 or RPMI 1640 supplemented with glucose and glutamine). The experiments were conducted using two levels for each factor studied and a direct ELISA test was used to estimate the level of antibody production. Statistical analysis of the collected data pointed to the stirring speed and serum concentration, and the interaction between these parameters, as the components that affected cell growth. Antibody production was affected by these factors and by the nature of medium but also by the following two interactions: stirring speed/nature of serum and stirring speed/concentration of serum. This study emphasizes the value of using Taguchi’s methods as a basis for optimization of mAb production from a hybridoma culture, in cost effective and significantly less labor intensive ways.

Keywords: Experimental design, Hybridoma, Monoclonal antibody, Production, Taguchi

Full Text

The Full Text of this article is available as a PDF (172.9 KB).

References

  1. Aujame L., Seguin D., Droy C., Hessler C. Experimental design optimisation of filamentous phage transfect mammalian cells by cationic lipids. Biotechniques. 2000;28:1202–1208. doi: 10.2144/00286rr01. [DOI] [PubMed] [Google Scholar]
  2. Burch G.J., Ferguson C.H., Cartwright G. and Kwong F.Y. 1995. Application of Taguchi experimental design to the optimization of baculovirus expression system. Biochem. Soc. Trans. 23: 107S. [DOI] [PubMed]
  3. Cobb B.D., Clarkson J.M. A simple procedure for optimizing the polymerase chain reaction (PCR) using modified Taguchi methods. Nucleic. Acids Res. 1994;22:3801–3805. doi: 10.1093/nar/22.18.3801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dhir S., Morrow K., Jr., Rhinehart R.R., Wiesner T. Dynamic optimization of hybridoma growth in a Fed-Batch Bioreactor. Biotechnol. Bioeng. 2000;67:197–205. doi: 10.1002/(SICI)1097-0290(20000120)67:2<197::AID-BIT9>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  5. Fielder U., Conrad U. High-level production and long term storage of engineered antibodies in transgenic tobacco seeds. Bio/Technology. 1995;13:1090–1093. doi: 10.1038/nbt1095-1090. [DOI] [PubMed] [Google Scholar]
  6. Goosen M.F.A. Insect culture engineering: an overview. In: Goosen M.F.A., Baugulis A., Faulkner, editors. Insect Cell Culture Engineering. New York: Marcel Dekker; 1993. pp. 1–16. [Google Scholar]
  7. Han J.J., Yang T.H., Rhee J.S. Optimization of reaction variables for sucrose monoester production using lipase in a solvent free system by Taguchi's method. Biotechnol. Techniques. 1998;12:295–299. doi: 10.1023/A:1008802331194. [DOI] [Google Scholar]
  8. Harlow E., Lane D. Antibodies: A Laboratory Manual. Boston: Cold Spring Harbor Laboratory; 1988. pp. 274–277. [Google Scholar]
  9. Jeney C., Dobay O., Lengyel A., Adam E., Nasz I. Taguchi optimization of ELISA procedures. J. Immunol. Methods. 1999;223:137–146. doi: 10.1016/S0022-1759(98)00185-9. [DOI] [PubMed] [Google Scholar]
  10. Kurkela R., Fraune E., Vihko P. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems. Biotechniques. 1993;15:674–683. [PubMed] [Google Scholar]
  11. Laroche-Traineau J., Clofent-Sanchez G., Santarelli X. Three-step purification of bacterially expressed human single-chain Fv antibodies for clinical applications. J. Chromatogr. B. Biomed. Sci. Appl. 2000;14:107–117. doi: 10.1016/S0378-4347(99)00441-7. [DOI] [PubMed] [Google Scholar]
  12. Maier S.T., Buchhioz R., Marx U. Influence of glucose, glutamine and oxygen on the metabolism of hybridomas and peripheral blood cells. In: Spier R.E., Griffiths J.B., Beuvery E.C., editors. Animal Cell Technology: Developments Towards the 21stCentury. Dordrecht: Kluwer Academic Publishers; 1995. pp. 235–239. [Google Scholar]
  13. Merten O.-W. Culture of hybridoma-a survey. In: Miller A.O.A., editor. Advanced Research on Animal Cell Technology. Dordrecht: Kluwer Academic Publishers; 1989. pp. 367–400. [Google Scholar]
  14. Miller W.M., Blanch H.W., Wilke C.R. A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: effect of nutrient concentration, dilution rate and pH. Biotechnol. Bioeng. 1988;32:947–965. doi: 10.1002/bit.260320803. [DOI] [PubMed] [Google Scholar]
  15. Oyaas K., Ellingsen T.E., Dyrset N., Levine D.W. Hyperosmotic hybridoma cell cultures: increased monoclonal production with addition of glycine betaine. Biotechnol. Bioeng. 1994;42:601–610. doi: 10.1002/bit.260440816. [DOI] [PubMed] [Google Scholar]
  16. Sanfeliu A., Cairo J.J., Casas C., Sola C., Godia F. the effect of medium composition on growth and monoclonal antibody production of hybridoma cells. In: Spier R.E., Griffiths J.B., Beuvery E.C., editors. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers; 1995. pp. 307–312. [Google Scholar]
  17. Taguchi G. Introduction to Quality Engineering. Asian Productivity Organization. New York: UNIPUB; 1986. [Google Scholar]
  18. Yang J.D., Angelillo Y., Chaudhry M., Goldenberg D.M., Glodenberg D.M. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process. Biotechnol. Bioeng. 2000;69:74–82. doi: 10.1002/(SICI)1097-0290(20000705)69:1<74::AID-BIT9>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES